APA (7th ed.) Citation

J, K., G, N., MN, F., JS, H., UL, M., E, A., . . . DR, S. (2024). Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genes. MedRxiv : the preprint server for health sciences. https://doi.org/10.1101/2024.10.09.24314324

Chicago Style (17th ed.) Citation

J, Kim, et al. "Genomic Ascertainment to Quantify Prevalence and Cancer Risk in Adults with Pathogenic and Likely Pathogenic Germline Variants in RASopathy Genes." MedRxiv : The Preprint Server for Health Sciences 2024. https://doi.org/10.1101/2024.10.09.24314324.

MLA (9th ed.) Citation

J, Kim, et al. "Genomic Ascertainment to Quantify Prevalence and Cancer Risk in Adults with Pathogenic and Likely Pathogenic Germline Variants in RASopathy Genes." MedRxiv : The Preprint Server for Health Sciences, 2024, https://doi.org/10.1101/2024.10.09.24314324.